Log in to save to my catalogue

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87bfe25f79a54057abdc226ad6b90aeb

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

About this item

Full title

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-10, Vol.13 (1), p.18596-18596, Article 18596

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Major depressive disorder (MDD) is a chronic illness wherein relapses contribute to significant patient morbidity and mortality. Near-term prediction of relapses in MDD patients has the potential to improve outcomes by helping implement a ‘predict and preempt’ paradigm in clinical care. In this study, we developed a novel personalized (N-of-1) enco...

Alternative Titles

Full title

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_87bfe25f79a54057abdc226ad6b90aeb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87bfe25f79a54057abdc226ad6b90aeb

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-44592-8

How to access this item